Jon Scholefield

Jon Scholefield is the current VP and Managing Director of UK Mahana Therapeutics. Prior to this, they worked as the Director of Commercial Operations for Northern Europe at Zoetis Inc. from December 2012 to February 2019. In this role, they were responsible for strategic pricing, field force effectiveness, systems and analytics, channel management, customer service, and fleet. Before Zoetis, they worked at Pfizer from January 2020 to January 2021 as a Global Commercial Excellence Advisor and Project Manager for the Pfizer Upjohn - Mylan Merger. In this role, they provided independent advice and project management to Pfizer Upjohn's Global Commercial Excellence team in preparation for the merger of Upjohn with Mylan to create a new organisation, Viatris.

Jon Scholefield has a Master of Engineering from the University of Cambridge. Jon also has a degree in engineering from the University of Cambridge, where they studied aerodynamics, turbomachinery, structures, control systems. Jon attended Westminster School London.

They work with Myla Puyat - VP Finance & Operations, Adam Hardin - VP of Clinical Operations, and Ann Montgomery - CPO. Jon Scholefield reports to Steven Basta, CEO.